International variation in treatment procedures for ADHD: Social context and recent trends

Psychiatric Services

Volumn 62, Issue 5, 2011, Pages 459-464

  Hinshaw, Stephen P ^a   Scheffler, Richard M ^a   Fulton, Brent D ^a   Aase, Heidi ^b   Banaschewski, Tobias ^c   Cheng, Wenhong ^d   Mattos, Paulo ^e   Holte, Arne ^b   Levy, Florence ^f   Sadeh, Avi ^g   Sergeant, Joseph A ^h   Taylor, Eric ⁱ   Weiss, Margaret D ^j  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g TEL AVIV UNIVERSITY   (Israel)

^h VU UNIVERSITY AMSTERDAM   (Netherlands)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PSYCHOTROPIC AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; AUSTRALIA; BRAZIL; CANADA; CHINA; CULTURAL VALUE; ECONOMIC ASPECT; EVIDENCE BASED PRACTICE; FEMALE; GERMANY; HEALTH CARE COST; HUMAN; ISRAEL; MALE; NETHERLANDS; NORWAY; POLITICS; PSYCHOANALYSIS; PSYCHOSOCIAL CARE; REIMBURSEMENT; TREATMENT DURATION; UNITED KINGDOM; UNITED STATES;

EID: 79955662283     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.62.5.pss6205_0459     Document Type: Article

References (33)

1. Faraone SV, Sergeant J, Gillberg C, et al: The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104-113, 2003
2. Timimi S, Taylor E: ADHD is best understood as a cultural construct. British Journal of Psychiatry 184:8-9, 2004 (Pubitemid 38085208)
3. Polanczyk G, de Lima MS, Horta BL, et al: The worldwide prevalence of ADHD: a systematic review and meta-regression analysis. American Journal of Psychiatry 164:942-948, 2007 (Pubitemid 46972911)
4. Scheffler RM, Hinshaw SP, Modrek S, et al: The global market for ADHD medications. Health Affairs 26:450-457, 2007
5. Farbstein I, Mansbach-Kleinfeld I, Levinson D, et al: Prevalence and correlates of mental disorders in Israeli adolescents: Results from a national mental health survey. Journal of Child Psychology and Psychiatry 51:630-639, 2010
6. Fulton B, Scheffler RM, Hinshaw SP, et al: National variation of ADHD diagnostic prevalence and medication use: health care providers and educational policies. Psychiatric Services 60:1075-1083, 2009
7. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision. Washington, DC, American Psychiatric Association, 2000
8. ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva, World Health Organization, 1993
9. Sawyer MG, Arney FM, Baghurst PA, et al: The mental health of young people in Australia: key findings from the child and adolescent component of the National Survey of Mental Health and Well-Being. Australian and New Zealand Journal of Psychiatry 35:806-814, 2001 (Pubitemid 34048452)
10. 2009 Australian Guidelines on Attention Deficit Hyperactivity Disorder (ADHD) Draft. Canberra, Australia, Royal Australian College of Physicians and National Health and Medical Research Council, 2009
11. Gomes M, Palmimi A, Barbirato F, et al: Knowledge about attention-deficit hyperactivity disorder in Brazil [in Portuguese]. Jornal Brasileiro de Psiquiatria 56:94-101, 2007 (Pubitemid 351211517)
12. Azevedo PVB, Caixeta L, Andrade LH, et al: Attention deficit hyperactivity disorder symptoms in indigenous children from the Brazilian Amazon [in Portuguese]. Arquivos de Neuro-Psiquiatria 68:541-544, 2010
13. Lu L, Shi Q, Tao F, et al: Epidemiological study on subtypes of ADHD of children aged 4 to 16 years-old in Wuhan [in Chinese]. Chinese Mental Health Journal 20:221-225, 2006
14. Sun D, Yi J, Li M, et al: An investigation of ADHD and family environment in 8235 school children aged 4-16 years in Northern Shandong [in Chinese]. Chinese Journal of Nervous and Mental Disease 35: 650-654, 2009
15. Ministry of Health Decree, Prescription Management. Ministry of Health Decree no 53.2007.5. Psychiatry Branch of Chinese Medical Association: Chinese Classification and Diagnostic Criteria of Mental Disorders 3 (CCMD-3) [in Chinese]. Jinan, China, Shandong Science and Technology Press, 2007
16. Schlander M, Viapiano M, Bonauer N: Who cares for patients with attention deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision. European Child and Adolescent Psychiatry 16:430-438, 2007
17. Schlander M, Trott GE, Schwarz O: The health economics of attention deficit hyperactivity disorder in Germany. part 1: health care utilization and cost of illness [in German]. Nervenarzt 81:289-300, 2010
18. Birnbaum HG, Kessler RC, Lowe SW, et al: Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Current Medical Research and Opinion 21:195-206, 2005
19. Pelham WE, Foster EM, Robb JA: The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Journal of Pediatric Psychology 32:711-727, 2007 (Pubitemid 47356048)
20. Secnik K, Swensen A, Lage MJ: Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics 23:93-102, 2005 (Pubitemid 40194012)
21. Swensen A, Birnbaum HG, Ben Hamadi R, et al: Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. Journal of Adolescent Health 35:346.e1-9, 2004
22. Schoffski O, Sohn S, Happich M: Overall burden to society caused by hyperkinetic syndrome (HKS) and attention deficit hyperactivity disorder (ADHD) [in German]. Gesundheitswesen 70:398-403, 2008
23. Fogelman Y, Vinker S, Guy N, et al: Prevalence of and change in the prescription of methylphenidate in Israel over a 2-year period. CNS Drugs 17:915-919, 2003 (Pubitemid 37211114)
24. Mansbach-Kleinfeld I, Farbstein I, Levinson D, et al: Service use for mental disorders and unmet need: Results from the Israel Survey on Mental Health Among Adolescents. Psychiatric Services 61:241-249, 2010
25. Recommendations for Diagnostics and Treatment of AD/HD [in Norwegian]. Oslo, Norway, Sosial-og Helsedirektoratet, 2007
26. National Survey of Service Availability for Diagnostics and Treatment Offers for Children and Adolescents With Hyperkinetic Disorder /ADHD [in Norwegian]. Trondheim, Norway, SINTEF Helse, 2004
27. Collishaw S, Maughan B, Goodman R, et al: Time trends in adolescent mental health. Journal of Child Psychology and Psychiatry 45:1350-1362, 2004 (Pubitemid 39445603)
28. Taylor E, Sandberg S, Thorley G, et al: The Epidemiology of Childhood Hyperactivity; Maudsley Monograph no 33. Oxford, Oxford University Press, 1991
29. Meltzer H, Gatward R, Goodman R, et al: Mental Health of Children and Adolescents in Great Britain. London, Office of National Statistics, 2000
30. Taylor E: Developing ADHD. Journal of Child Psychology and Psychiatry 50:126-132, 2009
31. Prendergast M, Taylor E, Rapoport JL, et al: The diagnosis of childhood hyperactivity: a US-UK cross-national study of DSM-III and ICD-9. Journal of Child Psychology and Psychiatry and Allied Disciplines 29:289-300, 1988
32. National Institute for Health and Clinical Excellence (NICE): Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. London, British Psychological Society and Royal College of Psychiatrists, 2009
33. Sayal K, Taylor E, Beecham J, et al: Pathways to care in children at risk of attention-deficit hyperactivity disorder. British Journal of Psychiatry 181:43-48, 2002 (Pubitemid 34717837)